Physician profile
Patrice D Kiesling
NPI 1790158723
$2,102.26
in general payments reported to CMS, 2019-2025
23 companies · $560 in 2025
The $560 reported for 2025 was more than what 76% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $896 · 2023: $315 · 2024: $143 · 2025: $560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,017.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $240.37 | 2022-2023 | Senza |
| Amgen INC. | $223.58 | 2022 | |
| Medtronic, INC. | $214.68 | 2022-2025 | Inceptiv, Signia |
| Globus Medical, INC. | $192.72 | 2025 | Senza |
| Mml US, INC. | $163.78 | 2022 | |
| Pfizer INC. | $141.80 | 2024-2025 | |
| Biohaven Pharmaceuticals, INC. | $130.21 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $116.01 | 2024-2025 | Relistor |
| Astrazeneca Pharmaceuticals LP | $113.16 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $82.48 | 2024-2025 | |
| Hologic Sales and Service, LLC | $77.33 | 2022-2023 | Thinprep 2000 Processor, Aptima |
| Abbvie INC. | $62.48 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $61.89 | 2022 | |
| Collegium Pharmaceutical, INC. | $60.88 | 2022-2024 | Xtampza |
| Scilex Pharmaceuticals INC. | $47.40 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $33.16 | 2022-2023 | |
| Orthofix Medical, INC. | $25.00 | 2022 | |
| Grt US Holding, INC. | $24.16 | 2022 | |
| Horizon Therapeutics Plc | $22.25 | 2023 | Krystexxa |
| Zimmer Biomet Holdings, INC. | $20.57 | 2024 | Gps III Platelet Concentration System |
| Alexion Pharmaceuticals, INC. | $18.86 | 2021 | |
| Daiichi Sankyo INC. | $16.15 | 2021 | |
| Novo Nordisk INC | $13.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrice Kiesling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.